Table 2 Univariate analysis of prognostic factors for overall survival
From: OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
Patient | Kaplan-Meier, Log-Rank test | |||
|---|---|---|---|---|
N | % | 5-year survival | P-value | |
Age (years) | 0.270 | |||
≤ 40 | 13 | 12 | 46% | |
40–70 | 76 | 68 | 65% | |
≥ 70 | 22 | 20 | 64% | |
Gender | 0.181 | |||
Male | 63 | 57 | 70% | |
Female | 48 | 43 | 58% | |
Tumor location | 0.126 | |||
Right colon | 31 | 28 | 53% | |
Left colon | 25 | 23 | 72% | |
Rectum | 55 | 50 | 66% | |
Tumor differentiation | 0.119 | |||
Well | 6 | 5 | 69% | |
Moderate | 50 | 45 | 68% | |
Poor | 39 | 35 | 35% | |
mucous | 13 | 12 | 60% | |
Signet ring | 3 | 3 | 35% | |
Tumor size (cm) | 0.009 | |||
≤ 3 | 31 | 28 | 80% | |
3–5 | 53 | 48 | 65% | |
>5 | 27 | 24 | 44% | |
T stage | 0.000 | |||
T1 | 7 | 6 | 100% | |
T2 | 23 | 21 | 95% | |
T3 | 49 | 44 | 53% | |
T4 | 32 | 29 | 45% | |
N stage | 0.000 | |||
N0 | 58 | 52 | 82% | |
N1 | 27 | 24 | 52% | |
N2a | 8 | 7 | 50% | |
N2b | 18 | 16 | 28% | |
M stage | 0.000 | |||
M0 | 96 | 86 | 73% | |
M1 | 15 | 14 | 8% | |
Chemotherapy | 0.001 | |||
Yes | 35 | 32 | 42% | |
No | 76 | 68 | 76% | |
OLA1 score | 0.005 | |||
0 + 1 | 63 | 57 | 78% | |
2 + 3 | 48 | 43 | 48% | |